Stay updated with breaking news from Christopherb Fox. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.
A Phase 1 trial found that a freeze-dried, temperature-stable experimental tuberculosis vaccine was safe, well-tolerated and elicited robust antigen-specific serum antibody and Th1-type cellular immune responses.
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found it prompted immune response and was safe.
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found it prompted immune response and was safe.
A Phase 1 trial of a temperature-stable TB vaccine has shown that it is both safe and stimulates an immune response in healthy adults.